Contact this trialFirst, we need to learn more about you.
CAR T-cell Therapy
agenT-797 for Solid Tumors
Recruiting1 awardPhase 1
Providence, Rhode Island
This trial is testing a new immune cell therapy called agenT-797 in patients whose solid tumors have come back or didn't respond to other treatments. The therapy uses special immune cells from a donor to help the patient's body fight the cancer.
Fill-in a few details and create your profileSave answers to your profile & unlock recommendations.
We will keep your details privateWe won't share unless you give us permission. By completing this form you agree to our privacy policy and terms of service.
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.
By clicking start, you agree to our
terms of service